Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,462 total articles
Wabtec (WAB) is showing continued earnings strength, a record backlog and contract wins that support upside. Fundamentals — $1.71B free cash flow, $49.3B market cap, and an improving technical setup — argue for a tactical long. Valuation is not cheap, so position sizing and a clear stop are essential.
Smart Sand (SND) looks positioned to benefit from rising proppant demand and favorable cash generation. At $5.36, shares trade at a modest multiple versus free cash flow and a sub-$250M market cap — attractive for a tactical swing that captures higher utilization and contract momentum. Entry, stop and targets below.
Roku's pending acquisition by Fox Corporation and continued platform growth make the stock an actionable long trade. The deal should expand Roku's content pipeline, boost advertising scale and reduce content churn risks — catalysts that justify taking a long position at current levels ($153.42). Risk-managed entry, stop and target provided for a lo…
Capitol Federal Financial (CFFN) is a low-multiple regional savings bank trading at roughly $8.57 today. Recent earnings history and steady profitability ratios imply room for margin expansion to drive EPS higher. With a 4%+ yield, a P/B near 1x and manageable valuation, we favor a tactical long over the next 45 trading days (mid term) with a disci…
Suzano (SUZ) trades at a modest multiple and yields ~2.16%. The company is levered to hardwood eucalyptus pulp prices and has been active on strategic investments and liability management. If pulp prices normalize from current cyclical levels, SUZ could re-rate toward its 52-week highs; this trade proposes a long with a clear entry, stop and target…
British American Tobacco (BTI) is an attractive long trade at current levels because the market underestimates the scale and margin potential of Velo and other smoke-free formats. BTI offers a 6%+ yield today, a reasonable valuation (market cap $113.7B, P/E ~13.4), and clear catalysts over the next 6-12 months that could drive a re-rating as smoke-…
Gold.com (GOLD) trades at a low EV relative to free cash flow, modest leverage and a dividend yield close to 1.9%. Recent headlines around major miners - including Barrick's portfolio reshuffle and potential US redomiciliation - have pushed market participants to price Nevada-related upside as already realized. That optimism has flowed into the pre…
Uber is trading like a mature business while still growing revenue and generating large free cash flow. At $70, the stock offers a reasonable entry for a mid-term swing trade that bets on accelerating margin conversion and short-covering. The plan: long at $70.00, stop $63.00, target $85.00 over 45 trading days.
Calix trades near $34 after a steep derating from its 52-week high. The actionable buy hinges on sustained software monetization and margin conversion: if management can translate platform adoption into recurring revenue growth and improved free cash flow, the stock can re-rate toward $50 over the next 6-9 months. If that conversion stalls, downsid…
Eaton trades like a growth story but at premium multiples that compress the margin for error. With P/E near 44, EV/EBITDA ~29 and free cash flow yield under 3%, my momentum overlays and valuation checks favor a short. I outline an actionable trade: enter short around $438.00, stop at $452.00, primary target $380.00 over a mid-term horizon (45 tradi…
Energy Transfer's fee-driven midstream model is converting cash into visible shareholder returns: a 6.7% yield, multi-year distribution growth, and attractive FCF relative to market cap. At $20.62 the stock trades at a reasonable EV/EBITDA and a forward multiple below peers. This trade idea lays out an entry, stop and target for a swing trade that …
Zevra Therapeutics' long-term real-world data for MIPLYFFA strengthens the clinical and commercial thesis that the drug can stabilize Niemann-Pick disease type C. The stock trades at a market cap of roughly $636M and an EV of $490M, with free cash flow of $32.6M and a P/E near 11. The primary binary swing remains the European Medicines Agency re-ex…
International Seaways (INSW) has ripped higher alongside tanking spot rates and industry-wide tailwinds. The stock is near a 52-week high but valuation and cash flow metrics still look attractive. This is an actionable swing trade with defined entry, stop and target, plus explicit horizon guidance and risk controls.
Sandisk is trading below its summer highs after a meaningful pullback, but the company sits on a rare combination for a memory vendor: multi-year customer commitments, robust free cash flow ($11.49B), zero net debt and improving data-center mix. For traders willing to own the name into the next earnings cycle and vendor guidance from peers, a mid-t…
Verastem (VSTM) enters October with two potential re-rating events: a phase II VS-7375 KRAS G12D readout and accelerating commercial sales from its ovarian cancer co-pack. The setup favors a tactical long into and through the readout with clearly defined risk controls; success could re-rate the stock toward a double-digit handle, while failure or s…
Americas Gold and Silver (USAS) is a high-risk, high-reward play on continued silver tightness and improving operational execution. At roughly $1.50B market cap and trading near $4.43, the stock discounts previous optimism but offers asymmetric upside if production and margin tailwinds hold. This trade is a conviction buy with strict risk controls …
Cencora (COR) is a core buy here. Q3 fiscal 2026 showed 5.1% revenue growth to $84.76B and 12% adjusted EPS growth, and management raised full-year adjusted EPS guidance to $17.75-$17.95. At roughly $60B market cap, COR trades at ~23x P/E and ~12x EV/EBITDA with $4.06B in free cash flow - a reasonable multiple for a company central to the health-ca…
IMAX is positioned to benefit from sustained premium theatrical demand and expanding content distribution. At $52.62 the stock reflects growth expectations but still offers a favorable risk/reward if a near-term tentpole cycle and system sales accelerate. This trade idea lays out a concrete entry, stop and target for a mid-term swing trade that cap…
<p>Palantir (PLTR) remains a growth story with strong fundamentals, but recent developments around Nebius - a surging AI cloud provider that just locked billions in customer commitments - create a meaningful asymmetric risk for Palantir in the near-to-mid term. Nebius is raising capacity and customer commitments at a scale that suggests it will be …
Shoe Station (SHOE) is trading at $12.82 with a market cap of about $348.5M, an EV of $230.5M and free cash flow of $66.55M. Short interest spiked to 8.75M shares (about 49% of the float) as of 09/15/2026, creating asymmetric upside should fundamentals stabilize or a squeeze form. The company screens cheap on P/B (~0.51), EV/FCF (~3.5) and P/FCF, w…
SpaceX's ability to deploy mass with Starship opens a credible pathway to space-based solar or massive satellite power projects at the 10 GW scale. If the company pivots from pure connectivity to energy delivery, valuation considerations change materially. This trade proposes a long exposure into a hypothetical public listing level, with explicit e…
Intuitive Surgical (ISRG) is a market-leading surgical robotics franchise with durable procedure growth, strong free cash flow, and minimal leverage. After a period of multiple compression tied to cyclical U.S. growth and China weakness, the headline multiple has started to re-expand as procedure trends in India and Japan accelerate and management …
Petrobras (PBR) offers a rare mix: a 5.45% cash yield today, rock-bottom valuation (PE ~5.5, PB ~1.5) and multiple near-term operational catalysts. Technicals are extended, so target a disciplined entry and tight stop. This is a swing trade that leans long: buy on a controlled entry, book near-term gains around $28 and re-evaluate on earnings and p…
Clean Energy Fuels (CLNE) has been beaten down to the low $1s despite recent revenue beats and a pathway to positive adjusted EBITDA in 2026. Valuation metrics look inexpensive relative to growth prospects in renewable natural gas (RNG) and LNG fueling infrastructure. This trade idea lays out a clear entry, stop, and target for a mid-term rebound w…
Shares of Netskope have ripped higher after a bullish quarter and raised guidance. Fundamentals show durable subscription growth (Q2 revenue $220.5M, ARR $899M) and improving go-to-market efficiency, but profitability and cash flow remain a concern. This is a tactical long set for a mid-term push: enter near current levels, use a conservative stop …
